Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This locus encodes a long non-coding RNA identified as an antisense transcript overlapping the COL5A2 gene. It does not encode a protein and belongs to the lncRNA molecular class. There is currently no functional annotation, disease association, or indication that it serves as a therapeutic target. Its biological role may include regulation of COL5A2 gene expression, but this has not been experimentally validated.
Not applicable; no drugs are known to target this molecule directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to COL5A2 (ENSG00000297404).